Terms: = Sarcomas AND MAP2K4, MEK4, 6416, P45985, ENSG00000065559, SERK1, JNKK1, MKK4, PRKMK4, MAPKK4, JNKK, SEK1 AND Treatment
9 results:
1. Small-molecule inhibition of map2k4 is synergistic with RAS inhibitors in
Jansen RA; Mainardi S; Dias MH; Bosma A; van Dijk E; Selig R; Albrecht W; Laufer SA; Zender L; Bernards R
Proc Natl Acad Sci U S A; 2024 Feb; 121(9):e2319492121. PubMed ID: 38377196
[TBL] [Abstract] [Full Text] [Related]
2. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
3. Uterine leiomyosarcomas harboring map2k4 gene amplification are sensitive in vivo to PLX8725, a novel map2k4 inhibitor.
McNamara B; Harold J; Manavella D; Bellone S; Mutlu L; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MSZ; Yang K; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Burton EA; Inagaki H; Albers A; Zhang C; Bollag G; Schlessinger J; Santin AD
Gynecol Oncol; 2023 May; 172():65-71. PubMed ID: 36958197
[TBL] [Abstract] [Full Text] [Related]
4. Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Conforti F; Pala L; Pagan E; Viale G; Bagnardi V; Peruzzotti G; De Pas T; Bianco N; Graffeo R; Rocco EG; Vingiani A; Gelber RD; Coates AS; Colleoni M; Goldhirsch A
Breast Cancer Res; 2019 Dec; 21(1):153. PubMed ID: 31888717
[TBL] [Abstract] [Full Text] [Related]
5. Pulmonary carcinosarcoma: analysis from the Surveillance, Epidemiology and End Results database.
Sun L; Dai J; Wang X; Jiang G; Gonzalez-Rivas D; Song J; Zhang P
Interact Cardiovasc Thorac Surg; 2020 Jan; 30(1):4-10. PubMed ID: 31518405
[TBL] [Abstract] [Full Text] [Related]
6. Targetable Alterations in Adult Patients With Soft-Tissue sarcomas: Insights for Personalized Therapy.
Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
[TBL] [Abstract] [Full Text] [Related]
7. Identification of predictors for wound complications following preoperative or postoperative radiotherapy in extremity soft tissue sarcoma.
Stevenson MG; Ubbels JF; Slump J; Huijing MA; Bastiaannet E; Pras E; Hoekstra HJ; Been LB
Eur J Surg Oncol; 2018 Jun; 44(6):816-822. PubMed ID: 29472042
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNA-27a promotes proliferation, migration and invasion by targeting map2k4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract] [Full Text] [Related]
9. MAPK7 and map2k4 as prognostic markers in osteosarcoma.
Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Filho RJ; Juliano Y; Toledo SR
Hum Pathol; 2012 Jul; 43(7):994-1002. PubMed ID: 22154052
[TBL] [Abstract] [Full Text] [Related]
